Target intelligence / Profile preview

Vaccinia virus L1R protein (L1R)

Target
L1R
Molecular classification
Viral envelope protein, Transmembrane protein
01

Overview

The Vaccinia virus L1R protein (L1R or L1) is a 250-residue myristoylated transmembrane envelope protein expressed on the surface of the intracellular mature virion (IMV) form, with a 185-residue disulfide-bonded ectodomain (three intramolecular disulfide bonds linking cysteines 34-57, 49-136, and 116-158) and a C-terminal hydrophobic segment embedded in the viral membrane. Its structure, resolved to 1.51 Å, features a bundle of α-helices packed against a pair of two-stranded β-sheets, including a hydrophobic cavity near the N-terminus that shields the myristate moiety essential for virion assembly. L1R is essential for viral replication, cell entry (enabling virion core penetration into the host cytoplasm via lipid mixing), low-pH-triggered cell-cell fusion, and interacts peripherally with the entry/fusion complex (EFC) components like F9, L5, and A28, as well as indirectly with F9. It serves as a potent target for neutralizing antibodies and is a key component of experimental poxvirus vaccines, with structural conservation across orthopoxviruses like monkeypox virus.

Other names
L1 proteinL1
02

Biological functions

Viral entryMembrane fusionVirion assembly
03

Disease associations

Infection

Beyond the preview

Go deeper on Vaccinia virus L1R protein (L1R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaccinia virus L1R protein (L1R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call